By Mr Anthony Ghosh, Consultant Spinal Neurosurgeon, The Spine MDT
Patients with long-standing lower back pain often ask me about the Discseel Procedure, a fibrin injection that is said to seal a torn disc and ease pain. It is a genuinely interesting idea, and one I want to give a fair hearing. Below I explain what the procedure is, how it is meant to work, what the evidence actually shows, and why I am holding off before offering it to my own patients.
Quick answer
The Discseel Procedure is an injection of a biological glue called fibrin into a torn disc lining, with the aim of sealing the tear and helping the disc heal. The idea is reasonable, but the evidence is still early. In the main study, only around half of patients reached the minimum level of improvement that counts as meaningful, and the trial was run by the people behind the procedure rather than as an independent, randomised, placebo-controlled trial. Until that higher-quality evidence exists, I do not currently offer the procedure and would encourage patients to have any disc problem assessed carefully first.
The Discseel Procedure is the injection of a substance called fibrin into the outer lining of a spinal disc that is believed to be causing back pain. It is sometimes described as an intra-annular fibrin injection, because the fibrin is placed into the annulus, the disc's outer wall. It is marketed as a minimally invasive, non-surgical option for chronic lower back pain, often for people who have already tried other treatments without success.
The spine is built from a stack of bones called vertebrae. Between each pair of bones sits a disc, which acts as a cushion. Each disc has a soft inner core called the nucleus, which is often described as looking and feeling like a lump of crab meat, surrounded by a tough outer lining called the annulus, which is made of many layers.
The annulus can tear. When it does, disc material or fluid can leak out, and this can trigger inflammation that leads to pain. This type of pain, coming from the disc itself, is known as discogenic back pain.
If an MRI scan shows a disc with a small tear, a further test can be used to look more closely. A dye is injected into the disc under X-ray guidance to see whether the contrast leaks out, which would confirm a tear. At the same time, with the patient awake, the test can show whether the injection reproduces their usual pain. This is known as a discogram. Providers of the Discseel Procedure use their own version of this test, which they call an annulogram.
The thinking behind the procedure is borrowed from how the body heals a cut. When you cut yourself and bleed, your blood produces a substance called fibrin, which forms a large part of the clot and the scab that stops further bleeding. That fibrin scab then breaks down gradually as the wound heals.
The Discseel Procedure applies the same principle to the disc. Fibrin is injected into the torn annulus, with the aim that it seals the tear so that the disc can settle and heal over time.
It helps to look at the studies directly. An early study, designed mainly to look at safety, involved 15 patients who had the injection. The authors reported nine adverse events. They considered only two of these to be directly related to the injection itself, but one of those was discitis, a serious infection of the disc that can be difficult to treat.
A larger study, published in the journal Pain Physician, looked at people with chronic lower back pain who had already failed other treatments, including surgery and injections. These patients received the Discseel injection and were followed up over one, two and three years. The headline finding was that around 50% of patients achieved the minimum amount of improvement that can be classed as statistically significant.
That 50% figure needs careful reading. It means that around half of the patients in the study did not notice a significant improvement in their pain. Of the half who did improve, the result only just crossed the threshold for what counts as a meaningful change. To their credit, the authors were open about the limitations of the work.
Two limitations stand out. First, the study was carried out by the founders of the procedure rather than by an independent team, which is an important consideration when weighing up the results. Second, it was not a randomised controlled trial, which means it did not compare the injection against a placebo. A randomised, placebo-controlled trial is the standard needed to be confident that a treatment genuinely works, and it is the next step I would want to see.
There is one more factor that matters a great deal. Signs of disc wear, such as an annular tear, a disc bulge, or a dark disc on an MRI scan, are extremely common, and they are frequently found in people who have no back pain at all. This means that finding a tear on a scan does not automatically prove that the tear is the source of someone's pain. It is a key reason to be cautious about any treatment aimed at a disc abnormality seen on imaging.
I do not want to be dismissive. The team behind the Discseel Procedure deserve credit for testing a creative idea, and the underlying concept of sealing a tear with the body's own healing material is appealing. My honest position is simply that the current evidence is not yet strong enough. Before I would offer this treatment to my own patients, I would want to see a properly conducted randomised controlled trial. Promising is not the same as proven.
If you have chronic back pain, the most useful first step is a careful assessment of your symptoms alongside your scans, so that any treatment is matched to the true source of your pain rather than to an incidental finding.
If you are living with chronic back pain and weighing up your options, the most valuable thing you can do is have your symptoms and imaging reviewed carefully by a specialist, so that any treatment targets the real cause of your pain. Mr Anthony Ghosh is a Consultant Spinal Neurosurgeon and a UK authority in complex spine care, seeing patients in London and the South East, with remote consultations available for international patients.
To discuss your back pain and review your scans, book a consultation or visit spinemdt.com.
This article is for general information and education. It is not a substitute for individual medical advice. Always discuss your own diagnosis and treatment options with a qualified clinician.
With our head office located in Northampton, we have access to a network of clinic locations throughout the UK.
In addition to face-to-face appointments, we also offer remote video consultations. Many hospitals have set up secure video consultation access via popular video platforms such as MS Teams or Zoom, and if required the appointment staff can help you to set up these consultations.
Central London
9 Harley Street, London, W1G 9QY
Kent
BMI - Chelsfield Park Hospital
Private Consultations and Surgery
Bucks Cross Rd, Chelsfield, Orpington, BR6 7RG
Sevenoaks Medical Centre
Beadle House, London Road, Sevenoaks,
Kent, TN13 2JD
Private Consultations and Surgery
Spire Hartswood Hospital
Warley Road
Brentwood
CM13 3LE